Robinson Lori Jean
Known title: DirectorCIK: 0001788644
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Centene Expands CHOICE Arrangements in Indiana, Ohio, Oklahoma. Centene has rolled out new benefit programs that support its CHOICE arrangements in Indiana, Ohio and Oklahoma, signaling a push to broaden its managed care footprint. Analysts note the company’s turnaround still has room to grow, and its target price remains well above the current level. The broader managed‑care landscape is also shifting, with UnitedHealth reporting higher margins but lower membership, a trend that may influence competitive dynamics.
Transaction History
| KFY | ▲ Buy | Grant | 2,780 | $0 | 9/24/2026 | View on chart |
| KFY | ▼ Sell | Open Market | 2,000 | $139K | 10/14/2025 | View on chart |
| KFY | ▲ Buy | Grant | 2,720 | $0 | 9/18/2025 | View on chart |
| NC | ▲ Buy | Grant | 482 | — | 7/1/2025 | View on chart |
| NC | ▲ Buy | Grant | 868 | — | 4/1/2025 | View on chart |
| NC | ▲ Buy | Grant | 928 | — | 1/2/2025 | View on chart |
| NC | ▲ Buy | Grant | 974 | — | 10/1/2024 | View on chart |
| KFY | ▲ Buy | Grant | 2,550 | $0 | 9/25/2024 | View on chart |
| NC | ▲ Buy | Grant | 902 | — | 7/1/2024 | View on chart |
| CNC | ▲ Buy | Grant | 2,916 | $0 | 5/14/2024 | View on chart |
| NC | ▲ Buy | Grant | 814 | — | 4/1/2024 | View on chart |
| CNC | ▲ Buy | Option Exercise | 10,000 | $547K | 2/13/2024 | View on chart |
| CNC | ▼ Sell | Open Market | 10,000 | $774K | 2/13/2024 | View on chart |
| NC | ▲ Buy | Grant | 781 | — | 1/2/2024 | View on chart |
| NC | ▲ Buy | Grant | 810 | — | 10/2/2023 | View on chart |
| KFY | ▲ Buy | Grant | 3,890 | $0 | 9/21/2023 | View on chart |
| NC | ▲ Buy | Grant | 806 | — | 7/5/2023 | View on chart |
| CNC | ▲ Buy | Grant | 2,947 | $0 | 5/10/2023 | View on chart |
| CNC | ▼ Sell | Open Market | 1,400 | $93K | 4/27/2023 | View on chart |
| NC | ▲ Buy | Grant | 732 | — | 4/3/2023 | View on chart |
| NC | ▲ Buy | Grant | 588 | — | 1/3/2023 | View on chart |
| NC | ▲ Buy | Grant | 635 | — | 10/3/2022 | View on chart |
| KFY | ▲ Buy | Grant | 3,850 | $0 | 9/22/2022 | View on chart |
| CNC | ▼ Sell | Open Market | 1,200 | $111K | 7/28/2022 | View on chart |
| NC | ▲ Buy | Grant | 579 | — | 7/1/2022 | View on chart |
| CNC | ▲ Buy | Grant | 2,323 | $0 | 4/26/2022 | View on chart |
| NC | ▲ Buy | Grant | 841 | — | 4/1/2022 | View on chart |
| NC | ▲ Buy | Grant | 808 | — | 1/3/2022 | View on chart |
| NC | ▲ Buy | Grant | 1,014 | — | 10/1/2021 | View on chart |
| KFY | ▲ Buy | Grant | 2,050 | $0 | 9/29/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Korn Ferry Stock Faces Valuation Questions
Recent reports suggest Korn Ferry shares are trading at a discount relative to their earnings strength, prompting market debate over the company's growth story. The stock is currently near its 52-week low, which may explain why some analysts view the current price as undervalued. With an average analyst target of $90.25, there is a notable gap between the current trading level and professional forecasts.
Korn Ferry Stock Faces Valuation Questions. Recent reports suggest Korn Ferry shares are trading at a discount relative to their earnings strength, prompting market debate over the company's growth story. The stock is currently near its 52-week low, which may explain why some analysts view the current price as undervalued. With an average analyst target of $90.25, there is a notable gap between the current trading level and professional forecasts.